HEALTHCARE | Staff Reporter, Singapore

A*Star's enterprise office inks US$90m deal for healthcare deep-tech startups

Nasdaq-listed Aptorum Group and A*ccelerate seeks to develop up to 20 deeptech ventures up over the next five years.

Nasdaq-listed Aptorum Group, Aeneas Capital, and A*ccelerate Technologies, the enterprise office of A*STAR, have signed a US$90m agreement to co-create local deep tech startups in the healthcare and life sciences sector.

Through this agreement, Aptorum Group and A*ccelerate are looking at creating up to 20 deep tech ventures in Singapore over the next five years. These enterprises will use the technologies co-developed by A*STAR research institutes and Aptorum Group.

One of the areas both parties are looking into is the translation of A*STAR’s capabilities in medical image analytics and augmented reality, into real-time 2D and 3D magnetic resonance imaging (MRI) surgical imaging solutions for applications in the field of surgical robotics.

Aptorum Group and Aeneas Capital will also be launching a healthcare and life science strategic investment fund of up to US$200m. Aptorum Group and Aeneas Capital will also make acquisitions in identified technologies and businesses globally.

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.